Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$27.31M+30.4%-$39.23M+0.9%-$39.58M-27.0%-$31.17M-14.5%-$27.21M+9.4%
$589K-5.9%$626K-9.7%$693K-2.7%$712K-3.9%$741K-0.4%
$9.98M+9.3%$9.13M+5.8%$8.63M+30.9%$6.59M+10.3%$5.98M+9.8%
-$19.99M-11.0%-$18.01M+15.2%-$21.24M+25.2%-$28.37M+17.7%-$34.48M+15.6%
$1.03M+199%
-$993K-188%
$63.46M+106%$30.76M-8.1%$33.48M-14.6%$39.22M-11.9%$44.5M+17.3%
$10.01M+10.8%$9.03M+378%
-$20.3M-7.2%-$18.93M+14.6%-$22.16M+24.2%-$29.25M+17.6%-$35.51M+13.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does TriSalus Life Sciences, Inc. generate?
TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
What is TriSalus Life Sciences, Inc.'s free cash flow?
After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.